Publication | Open Access
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma
151
Citations
25
References
1998
Year
B-cell LymphomaLymphoid NeoplasiaHematological MalignancyMedicineImmunologyPharmacokinetic StudyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1